Baycrest fMRI study with 45 people utilized Vielight intranasal PBM technology, triggering a response from the thalamus, surpassing transcranial-only PBM for deep brain stimulation.
The first multimodal sham-controlled MCI PBM trial suggests improved cognition with Vielight itPBM, conducted by psychiatrists at the University of Toronto.
Published in Brain Stimulation (n=45): Vielight intranasal PBM triggered CSF changes in 4 minutes, using ~5% of the energy required by transcranial delivery.
A Nature Scientific Reports study marks the only high-level journal publication demonstrating direct EEG neuromodulation with a commercial brain PBM device.
A University of Utah n = 43 trial shows Vielight Neuro itPBM significantly improves reaction time, bilateral grip strength, and postural balance in athletes.
Health Canada expands the Vielight RX Plus medical device license to cover upper respiratory symptom recovery for all viral infections based on an n=294 RCT.
Here is a reasonable assumption: if two wellness devices both shine near-infrared light at the nervous system (intranasal + vagus or intranasal + transcranial), and [...]
Vielight is featured in research that suggests anti-brain aging mechanisms by optimizing cognition, optimizing mitochondrial ATP, systemic immunity, and HRV.
Watch the physics of full transcranial coverage: See how Neuro volumetric diffusion focuses on major brain networks while the intranasal module targets deep structures.
Live in Toronto with MCI? Join the University of Toronto clinical trial evaluating the Vielight Neuro RX Gamma for memory changes and mild cognitive decline.